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Background & aims: The association between circulating n-3 polyunsaturated fatty acid (PUFA) bio-
markers and incident type 2 diabetes in Asian populations remains unclear. We aimed to examine the
association of erythrocyte n-3 PUFA with incident type 2 diabetes in a Chinese population.
Methods: A total of 2671 participants, aged 40e75 y, free of type 2 diabetes at baseline, were included in
the present analysis. Incident type 2 diabetes cases (n ¼ 213) were ascertained during median follow-up
of 5.6 years. Baseline erythrocyte fatty acids were measured by gas chromatography. We used multi-
variable Cox regression models to estimate the hazard ratios (HRs) and 95% conﬁdence intervals (CIs) of
type 2 diabetes across quartiles of erythrocyte n-3 PUFA.
Results: After adjustment for potential confounders, HRs (95% CIs) of type 2 diabetes were 0.68 (0.47,
1.00), 0.77 (0.52, 1.15), and 0.63 (0.41, 0.95) in quartiles 2e4 of docosapentaenoic acid (C22:5n-3) (P-
trend ¼ 0.07), compared with quartile 1; and 1.08 (0.74, 1.60), 1.03 (0.70, 1.51), and 0.57 (0.38, 0.86) for
eicosapentaenoic acid (C20:5n-3) (P-trend ¼ 0.007). No association was found for docosahexaenoic acid
(C22:6n-3) or alpha-linolenic acid (C18:3n-3).
Conclusions: Erythrocyte n-3 PUFA from marine sources (C22:5n-3 and C20:5n-3), as biomarkers of di-
etary marine n-3 PUFA, were inversely associatedwith incident type 2 diabetes in this Chinese population.
Future prospective investigations in other Asian populations are necessary to conﬁrm our ﬁndings.
© 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).dence interval; DHA, docosa-
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Prospective associations between dietary n-3 polyunsaturated
fatty acids (PUFA) and type 2 diabetes (T2D) have been inconsistent
in the published literature [1e5]. Several prior meta-analyses have
suggested that overall dietary intake of marine n-3 PUFA (including
docosahexaenoic acid [DHA, C22:6n-3], docosapentaenoic acid
[DPA, C22:5n-3] and eicosapentaenoic acid [EPA, C20:5n-3]) was
not associated with incident T2D, but reﬂected substantial het-
erogeneity by geographic region: there was an inverse association
in Asian populations (mainly Chinese), but a positive association in
US populations and a null association in European populations
[2,4,5]. Similar inconsistencies were found for the association be-
tween dietary alpha-linolenic acid (ALA, C18:3n-3), a plant-based
n-3 PUFA, and T2D incidence [3,5].under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
yte n-3 polyunsaturated fatty acids with incident type 2 diabetes in a
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dietary questionnaires, as adopted by the majority of the previ-
ous observational studies, is known to be subject to measure-
ment error and recall bias, with compromised accuracy [6]. Using
objectively measured circulating biomarkers of n-3 PUFA to
examine the association with T2D could overcome the above
limitations of dietary measurement, although there are still very
few studies linking objectively measured circulating n-3 PUFA
with T2D incidence [7e12]. In a recent study, Forouhi et al.
examined the prospective association between individual plasma
phospholipid PUFA and T2D incidence in the EPIC-InterAct study
and further conducted a comparative meta-analysis of the pub-
lished literature [7]. The results suggested that ALA was inversely
associated with incident T2D, while no association was found for
EPA or DHA. Of note, all the above evidence was generated from
observational studies in Western populations, including Austra-
lian, US, and European participants [7]. So far, to the best of our
knowledge, there has been no study among Chinese populations
examining the association between circulating n-3 PUFA and
incident T2D.
The aim of the present study was to investigate the association
between objectively measured individual n-3 PUFA in red blood
cells (erythrocytes) and incident T2D in a community-based pro-
spective cohort study in southern China. We hypothesized that
erythrocyte marine n-3 PUFA were inversely associated with inci-
dent type 2 diabetes in the Chinese population.
2. Materials and methods
2.1. Study design and study population
Our study was based on the Guangzhou Nutrition and Health
Study (GNHS), a community-based prospective cohort study in
the urban area of southern China. Detailed study designs have
been reported previously [13]. Brieﬂy, between 2008 and 2013,
4048 participants, aged 40e75 years old, living in urban
Guangzhou city for at least 5 years, were recruited into the
GNHS; there were two waves of participant recruitment using
the same criteria: between 2008 and 2010 (n ¼ 3169), and be-
tween 2012 and 2013 (n ¼ 879). All participants were followed
up every 3 years, and up to May 31, 2017, two follow-up visits
were performed for participants recruited between 2008 and
2010, and one follow-up visit for participants recruited between
2012 and 2013.
At baseline, we excluded those without valid questionnaire in-
formation on age or sex (n ¼ 18), those with self-reported baseline
cancers (n ¼ 19), chronic renal dysfunction (n ¼ 4), self-reported/
diagnosed T2D (n ¼ 323), or those without measurement of base-
line erythrocyte membrane fatty acid compositions (n ¼ 387). We
also excluded those with missing covariates (n ¼ 108) and those
with extreme levels of total energy intake (men: <800 kcal or
>4000 kcal; women: <500 kcal or >3500 kcal) (n¼ 47). We further
excluded those without follow-up information (n ¼ 471, 85%
follow-up rate). Finally, 2671 participants were included in the
present analysis, with a median 5.6 years of follow-up. A ﬂow-chart
showing detail of inclusion and exclusion criteria is shown in
Supplemental Fig. 1.
Incident T2D cases (N ¼ 213) were ascertained on the basis of
fasting blood glucose 7.0 mmol/L or HbA1c  6.5% or currently
under medical treatment for diabetes at either of the two follow-
up visits, according to the American Diabetes Association criteria
for the diagnosis of diabetes [14]. The study protocol was
approved by the Ethics Committee of the School of Public Health
at Sun Yat-sen University, and all participants provided written
informed consent.Please cite this article in press as: Zheng J-S, et al., Association of erythroc
Chinese population, Clinical Nutrition (2018), https://doi.org/10.1016/j.cln2.2. Measurement of erythrocyte membrane fatty acids
Venous blood sampleswere collected after overnight fast (>12 h),
and erythrocyteswerewashed and separatedwithin 2 h of collection
and stored at 80 C. Erythrocyte membrane total fatty acid com-
positions were measured using gas chromatography (7890 GC, Agi-
lent, California; DB-23 capillary column: 60 m  0.25 mm internal
diameter  0.15 mm ﬁlm, Agilent, California, USA) as described pre-
viously [15,16]. Commercially available standards (Nu-Chek Prep,
Minnesota, USA) were used to identify individual fatty acids. Intra-
assay coefﬁcients of variation for DHA, DPA, EPA, and ALA were
11.4%, 8.1%, 14.6%, and 9.9%, respectively. Individual erythrocyte fatty
acids were expressed as relative concentration (%) among the total
fatty acids.
2.3. Measurement of dietary intake and other covariates
At baseline, socio-demographic factors, lifestyle and dietary
factors, and medical history information were all gathered by
questionnaire during face-to-face interviews. Habitual dietary in-
takes over the past 12 months were assessed by a validated food
frequency questionnaire, as previously described in detail [17].
Dietary macronutrients (fat, protein and carbohydrate) were
adjusted for total energy intake using the residual method [18].
Physical activity was assessed as total metabolic equivalent for task
(MET) hours per day on the basis of a validated questionnaire for
physical activity [19]. Anthropometric parameters, including
weight, height, waist, and hip circumference, were measured by
trained nurses at the site during the baseline interview.
Fasting venous blood samples were taken at each recruitment or
follow-up visit. Serum low-density lipoprotein cholesterol and
glucose were measured by colorimetric methods using a Roche
cobas 8000 c702 automated analyzer (Roche Diagnostics GmbH,
Shanghai, China). Intra-assay coefﬁcients of variation (CV) were
3.1% for low-density lipoprotein cholesterol and 2.5% for glucose.
High-performance liquid chromatography was used to measure
glycated hemoglobin (HbA1c) using the Bole D-10 Hemoglobin A1c
Program on a Bole D-10 Hemoglobin Testing System, and the intra-
assay CV was 0.75%.
2.4. Statistical analysis
Statistical analysis was performed using Stata 14 (StataCorp, Col-
lege Station, TX, USA). All erythrocyte fatty acid variables were win-
sorized using values representing the 1st and 99th percentiles of the
distribution in the cohort. Difference in population characteristics
between participants with and without follow-up information was
examined by analysis of covariance (continuous variables) or chi-
square test (categorical variables). Spearman correlation coefﬁcients
were calculated to examine the correlation between dietary intakes of
ﬁsh and individual n-3PUFA with individual erythrocyte n-3PUFA.
As a primary analysis, we used Cox regression with age as the
underlying timescale to estimate the HR and 95% CI for T2D
comparing quartiles of each n-3 PUFA variable (total marine n-3
PUFA, DHA, DPA, EPA, and ALA) using three statistical models: model
1 included age (continuous, years), sex (men, women), BMI
(continuous, kg/m2) and ratio of waist to hip circumference
(continuous); model 2, as model 1þ physical activity (quintiles 1e5,
based onMET hours), education (middle school or lower, high school
or professional college, university), alcohol drinking (current and
non-current drinker), smoking (current and non-current smoker),
household income (500, 501e1500, 1501e3000, >3000 Chinese
Yuan/month/person), family history of diabetes (yes, no), total en-
ergy intake (continuous, kcal/d) and dietary intake (all diet variables:
in quartiles) of dairy products, red and processed meat, fruits andyte n-3 polyunsaturated fatty acids with incident type 2 diabetes in a
u.2018.09.018
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uous, mmol/L) and erythrocyte total n-6 PUFA (continuous,mmol/L).
P-trend was estimated based on per-quartile increase in the corre-
sponding fatty acid.We performed several sensitivity analyses based
on the above model 3 to examine the robustness of the results (3a):
excluded participantswith less than one year of follow-up in order to
assess the potential inﬂuence of reverse causality (3b); included
serum LDL-C as an additional covariate as to assess the potential
inﬂuence of blood lipids (3c); included additional dietary variables
(total fat intake, coffee, fruit juice, and tea) as covariates.
We used a restricted cubic spline model with 3 knots (at 10th,
50th, and 90th) [20] to explore the shape of the association be-
tween erythrocyte n-3 PUFA and incident T2D, adjusting for the
covariates as in model 3. P-values for nonlinearity were calculated
using a Wald test of the relevant parameter from the restricted
cubic splinemodel. In order to allow comparisonwith the literature
with per standard deviation (SD) estimation, HRs (95% CI) of T2D
per SD increase in the individual erythrocyte n-3 PUFA were also
estimated in Cox regression models, adjusted for potential con-
founders (i.e., model 3).
As secondary analyses, we examined the HRs (95% CI) comparing
quartiles of dietary ﬁsh and n-3 PUFA intake with T2D risk using the
same models (model 1 to model 3) used in the above primary an-
alyses.We also examined the HRs (95% CI) of T2D by quartiles of total
erythrocyte n-3/n-6 PUFA ratio and erythrocyte EPA/AA ratio to
investigate the association of the ratio with the T2D risk.
3. Results
The mean age and BMI of the study participants was 58 y (SD:
5.7 y) and 23.2 kg/m2 (SD: 3.0 kg/m2), respectively. The mean levels
of erythrocyte DHA, DPA, EPA, and ALA (% total fatty acids) were 4.5
(SD: 1.29), 1.52 (SD: 0.39), 0.77 (SD: 0.57), and 0.09 (SD: 0.03),Table 1
Population characteristics by quartiles of erythrocyte n-3 polyunsaturated fatty acidsa.
Erythrocyte marine n-3 PUFA (EPA þ DPA þ D
Q1 Q2 Q3
Age, y 58.0 (5.4) 58 (5.7) 58.2 (6.1)
BMI, kg/m2 23.3 (3.1) 23.3 (3.1) 23.1 (2.9)
Waist circumference, cm 83.0 (9.0) 83.0 (8.8) 82.5 (8.8)
Ratio of waist to hip circumference 0.89 (0.07) 0.89 (0.07) 0.89 (0.07)
Total energy intake, kcal/d 1832 (498) 1785 (502) 1742 (461)
Physical activity, MET hours/d 42.7 (16) 41.4 (14.5) 40.7 (14.7)
Dairy intake, g/d 15.7 (13.2) 17.7 (15.2) 16.3 (14.5)
Red and processed meat intake, g/d 89.2 (55.7) 86.1 (59.0) 80.0 (48.0)
Vegetable intake, g/d 391.4 (277.5) 370.2 (172.3) 383 (257.7)
Fruit intake, g/d 149.6 (113.3) 149.9 (118.3) 143.5 (108.7)
Fish intake, g/d 51.4 (90.5) 52.7 (68.1) 52.1 (52)
Marine n-3 PUFA intake, g/d 0.06 (0.11) 0.06 (0.07) 0.07 (0.07)
Alpha-linolenic acid intake, g/d 0.84 (0.39) 0.86 (0.43) 0.81 (0.37)
Fasting blood glucose, mmol/L 4.6 (0.7) 4.8 (0.6) 4.7 (0.7)
Sex, % of women 67.8 69.4 68.1
Current alcohol drinking, % 6.8 5.8 6.8
Current smoking status, % 17.6 14.2 16.5
Family history of diabetes, % 10.0 10.6 10.1
Household income (Chinese Yuan/month/person), %b
500 2.5 2.0 1.5
501e1500 26.6 28.0 26.3
1501e3000 51.6 56.8 56.8
>3000 19.4 13.2 15.5
Education, %
Middle school or lower 30.1 27.5 27.9
High school or professional college 43.1 48.5 46.4
University 26.7 24.0 25.7
a Total number of participants included in the present study was 2671. Abbreviation: E
ALA, alpha-linolenic acid; PUFA, polyunsaturated fatty acids; Q, quartile. Themedian level
0.06%, 0.07%, 0.09%, and 0.12% for quartiles 1e4 of ALA.
b 1 Chinese Yuan corresponds to around 0.16 US dollar.
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Chinese population, Clinical Nutrition (2018), https://doi.org/10.1016/j.clnrespectively. The population characteristics by quartiles of total
erythrocyte marine n-3 PUFA and by ALA are presented in Table 1.
Supplemental Table 1 presents population characteristics among
participants with and without follow-up information. Participants
lost to follow-up tended to be less physically active, consumed
fewer vegetables, had higher serum glucose levels, and were less
educated. Dietary ﬁsh intakewas signiﬁcantly (P < 0.001) positively
correlated with erythrocyte DHA (r ¼ 0.19), DPA (r ¼ 0.08) and EPA
(r ¼ 0.11) (Supplemental Table 2).
There was no association between total or individual erythro-
cyte marine n-3 PUFA and T2D incidence in model 1 or model 2,
adjusting for baseline socio-demographic, lifestyle, and dietary
factors (Table 2). After further adjustment for baseline circulating
biomarkers (fasting glucose and n-6 PUFA) in model 3, HRs (95% CI)
of T2D at Q2, Q3, and Q4 compared with Q1 for erythrocyte DPA
were 0.68 (0.47, 1.00), 0.77 (0.52, 1.15), and 0.63 (0.41, 0.95) (P-
trend¼ 0.007), respectively. In addition, the highest quartile (Q4) of
erythrocyte EPA, compared with Q1, was inversely associated with
risk of incident T2D (HR: 0.57, 95% CI: 0.38, 0.86) (P-trend ¼ 0.007).
Erythrocyte ALAwas not associated with incident T2D in any of the
statistical models. Sensitivity analysis did not materially change the
above risk estimates (Supplemental Table 3).
Restricted cubic spline models did not identify evidence of non-
linearity, and the shapes of the association between levels of in-
dividual erythrocyte n-3 PUFA and total marine n-3 PUFA and
incident T2D are presented in Fig. 1 and Supplemental Fig. 2. A
linear inverse association between erythrocyte EPA and incident
T2D was noted in the multivariable-adjusted model (model 3) with
per SD HR 0.83 (95% CI 0.71, 0.98).
Dietary intake of ﬁsh, ALA, and total or individual marine n-3
PUFA were not associated with incident T2D in the multivariable-
adjusted model 3 (Table 3). Ratio of erythrocyte n-3/n-6 PUFA
was not associated with incident T2D, while ratio of EPA/AA wasHA) Erythrocyte ALA
Q4 Q1 Q2 Q3 Q4
57.7 (5.7) 58.7 (6.1) 58.0 (6.0) 57.7 (5.6) 57.4 (5.2)
23.0 (3.1) 23.4 (3.1) 23.4 (3.1) 23.1 (3.1) 22.9 (2.9)
82.4 (8.9) 83.5 (8.8) 83.2 (9.1) 81.9 (8.8) 82.1 (8.6)
0.89 (0.07) 0.90 (0.07) 0.89 (0.07) 0.88 (0.07) 0.89 (0.07)
1705 (458) 1789 (503) 1732 (474) 1744 (473) 1801 (475)
41.5 (14.4) 41.0 (14.5) 41.1 (14.8) 42.4 (15.4) 41.7 (15)
16.2 (14.7) 15.8 (14) 15.6 (12.8) 16.6 (15.4) 17.8 (15.3)
78.1 (48.5) 88.9 (54.8) 80.1 (49.9) 80.5 (51.4) 83.8 (55.6)
380.9 (165.4) 366.0 (183.0) 373 (252.5) 381.4 (197.4) 406.1 (253.5)
150.7 (100.1) 140.2 (109.1) 146.3 (106.4) 147.2 (106.7) 160.2 (117.6)
65.3 (78.1) 55.7 (88.6) 56.2 (61.3) 56.8 (92.3) 53 (41.1)
0.09 (0.12) 0.07 (0.13) 0.07 (0.07) 0.07 (0.11) 0.07 (0.05)
0.81 (0.36) 0.80 (0.33) 0.83 (0.37) 0.84 (0.42) 0.85 (0.42)
4.7 (0.6) 4.7 (0.7) 4.7 (0.7) 4.6 (0.6) 4.6 (0.7)
74.8 59.9 71.0 72.4 76.8
6.6 9.0 4.1 7.4 5.6
11.9 22.1 12.9 13.7 11.5
10.6 8.7 11.0 10.2 11.4
2.1 1.1 2.6 2.4 2.0
24 25.2 25.5 26.8 27.3
60.6 58 57.2 55.9 54.6
13.3 15.8 14.7 14.9 16.1
28.3 28.7 29.3 27.4 28.5
48.4 44.1 46.8 46.8 48.6
23.3 27.2 23.9 25.8 22.9
PA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid;
s for quartiles 1e4 of marine n-3 PUFAwere 4.78%, 6.45%, 7.46%, and 8.72%, andwere
yte n-3 polyunsaturated fatty acids with incident type 2 diabetes in a
u.2018.09.018
Table 2
Association of erythrocyte n-3 fatty acids with incident type 2 diabetesa.
Erythrocyte fatty acids Multivariable-adjusted hazard ratio (95% CI)b
Q1 Q2 Q3 Q4 P-trend
Marine n-3 PUFA
(DHA þ DPA þ EPA)
Median, % 4.78 6.45 7.46 8.72
No. of cases/person-years of follow-up 59/3568 49/3252 56/3285 49/3345
Model 1 1 (ref) 0.89 (0.61, 1.30) 1.04 (0.72, 1.51) 0.92 (0.63, 1.34) 0.87
Model 2 1 (ref) 0.89 (0.61, 1.29) 1.04 (0.72, 1.50) 0.93 (0.63, 1.37) 0.93
Model 3 1 (ref) 0.74 (0.49, 1.11) 0.89 (0.60, 1.32) 0.96 (0.63, 1.45) 0.92
DHA Median, % 3.03 4.18 4.96 5.92
No. of cases/person-years of follow-up 53/3497 61/3338 46/3128 53/3486
Model 1 1 (ref) 1.17 (0.81, 1.70) 0.98 (0.66, 1.46) 1.13 (0.77, 1.66) 0.75
Model 2 1 (ref) 1.16 (0.80, 1.68) 0.98 (0.66, 1.46) 1.15 (0.78, 1.68) 0.69
Model 3 1 (ref) 1.15 (0.77, 1.73) 1.05 (0.68, 1.61) 1.52 (0.99, 2.34) 0.10
DPA Median, % 1.11 1.45 1.65 1.9
No. of cases/person-years of follow-up 64/3554 53/3416 52/3189 44/3290
Model 1 1 (ref) 0.88 (0.61, 1.26) 0.91 (0.63, 1.31) 0.76 (0.52, 1.11) 0.19
Model 2 1 (ref) 0.85 (0.59, 1.22) 0.94 (0.65, 1.36) 0.78 (0.53, 1.14) 0.29
Model 3 1 (ref) 0.68 (0.47, 1.00) 0.77 (0.52, 1.15) 0.63 (0.41, 0.95) 0.07
EPA Median, % 0.26 0.44 0.7 1.61
No. of cases/person-years of follow-up 55/3525 55/3414 56/3479 47/3032
Model 1 1 (ref) 1.02 (0.70, 1.48) 1.03 (0.71, 1.50) 0.84 (0.57, 1.25) 0.44
Model 2 1 (ref) 1.00 (0.69, 1.46) 1.01 (0.69, 1.47) 0.83 (0.56, 1.23) 0.39
Model 3 1 (ref) 1.08 (0.74, 1.60) 1.03 (0.70, 1.51) 0.57 (0.38, 0.86) 0.007
ALA Median, % 0.06 0.07 0.09 0.12
No. of cases/person-years of follow-up 52/3245 57/3368 53/3392 51/3445
Model 1 1 (ref) 1.08 (0.73, 1.58) 1.07 (0.73, 1.57) 1.04 (0.70, 1.55) 0.85
Model 2 1 (ref) 1.04 (0.70, 1.53) 1.05 (0.71, 1.54) 1.07 (0.71, 1.61) 0.74
Model 3 1 (ref) 1.00 (0.67, 1.48) 1.17 (0.80, 1.72) 1.07 (0.72, 1.60) 0.57
a Abbreviations: EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid; ALA, alpha-linolenic acid; PUFA, polyunsaturated fatty acids; Q,
quartile.
b Multivariable-adjusted hazard ratios (95% CI) were calculated for quintiles 2 to 4 of the erythrocyte n-3 fatty acids, compared with quintile 1. Model 1 was adjusted for age,
sex, BMI, and ratio of waist to hip circumference; model 2 included covariates in model 1 þ physical activity, education, alcohol drinking, smoking, household income, family
history of diabetes, total energy intake, and intake of dairy products, red and processed meat, fruits and vegetables; model 3 included covariates in model 2 þ fasting serum
glucose and erythrocyte total n-6 PUFA. P-trend was estimated based on per quartile increase in the corresponding fatty acid.
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and 0.49 at Q2, Q3, and Q4 (P-trend ¼ 0.002), respectively
(Supplemental Table 4).4. Discussion
The results of the present prospective cohort study among a
community-based Chinese population suggest that levels of
erythrocyte marine n-3 PUFA: DPA and EPA were inversely associ-
ated with risk of incident T2D, while there was no association for
erythrocyte DHA or ALA.
A few decades ago, ecological data consistently suggested low
prevalence of T2D among populations with high consumption of
ﬁsh and marine n-3 PUFA, which was especially true in Eskimos
[21]. The beneﬁcial role of marine n-3 PUFA in insulin secretion,
insulin sensitivity, and T2D has been hypothesized [21]. How-
ever, the ﬁndings of studies examining a prospective association
of dietary ﬁsh and marine n-3 PUFA with T2D have been
inconsistent. For example, dietary marine n-3 PUFA was not
associated with incident T2D in the Iowa Women's Health Study
[22], the Cardiovascular Health Study [23], or the Rotterdam
Study [24]. In the Shanghai Women's Health Study, higher intake
of marine n-3 PUFA was associated with a lower risk of incident
T2D [25]. In contrast, a positive association between marine n-3
PUFA intake and T2D was reported in the Nurses' Health Study
and Nurses' Health Study 2 [26]. The above evidence was sys-
tematically reviewed by several independent groups between
2012 and 2013 [2,4,5], and the meta-analyzed results suggested
that overall there was no association between marine n-3 PUFA
intake and T2D, with huge heterogeneity by geographical re-
gion: an inverse association in Asian populations, null orPlease cite this article in press as: Zheng J-S, et al., Association of erythroc
Chinese population, Clinical Nutrition (2018), https://doi.org/10.1016/j.clnpositive associations in US or European populations, and the
results regarding ﬁsh intake and T2D were consistent with those
of marine n-3 PUFA.
We did not ﬁnd a signiﬁcant association of dietary marine n-3
PUFA with T2D in the present study. However, the effect size of
the present study was very similar to that of the Shanghai
Women's Health Study (relative risk: 0.84 at quintile 5 versus
quintile 1) [25], and both suggested an inverse association of
dietary marine n-3 PUFA with T2D risk. In addition, the median
dietary intake of marine n-3 PUFAs in the above study in
Shanghai (0.07 g/d) was very close to that found in the present
study (0.05 g/d). The non-signiﬁcant results in the present study
might be because of the relatively moderate sample size (corre-
sponded to a wider conﬁdence interval) compared with the
previous study in Shanghai [25].
Objective measurements of n-3 PUFA in blood (including
erythrocyte, plasma, serum and whole blood, or related lipid frac-
tions) have been widely adopted by the scientiﬁc community as
biomarkers of dietary n-3 PUFA intake [27]. However, due to the
high cost and time-consuming nature of blood fatty acid mea-
surement, only a few prospective studies have reported the asso-
ciations between blood n-3 PUFA biomarkers and T2D incidence
[8e12,23,28,29]. In the European Prospective Investigation into
Cancer and Nutrition (EPIC)-InterAct study and a comparative
meta-analysis of studies in the literature, there was no signiﬁcant
association of DHA or EPA with incident T2D [7]. The above EPIC-
InterAct study, as well as the studies identiﬁed in the systematic
review within the same paper, was based exclusively on Western
populations. Meanwhile the prospective evidence from Asia is rare,
with only one nested case-control study (336 T2D cases) in Japan
published very recently, reporting a null association [30]. Therefore,yte n-3 polyunsaturated fatty acids with incident type 2 diabetes in a
u.2018.09.018
Fig. 1. Shape of the association between individual erythrocyte n-3 polyunsaturated fatty acids and incidence of type 2 diabetes. Restricted cubic spline functions were used to
estimate the association between individual erythrocyte n-3 polyunsaturated fatty acids and incident type 2 diabetes in the Cox regression models, adjusted for potential con-
founders (i.e. Model 3). Panels A, B, C and D represented results for erythrocyte DHA, DPA, EPA and ALA respectively. None of the associations showed non-linearity (P > 0.1). Hazard
ratios (95% CI) of type 2 diabetes per SD increase in the individual erythrocyte n-3 polyunsaturated fatty acids were also estimated in Cox regression models, adjusted for potential
confounders (i.e., Model 3). In addition, to make the dose-response association comparable with the quartile results, we also plotted the hazard ratio (95% CI) of type 2 diabetes
across quartiles 2e4 of the n-3 polyunsaturated fatty acids (quartile 1 as reference, location of each plot corresponds to the median levels within each quartile). EPA, eicosa-
pentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid; ALA, alpha-linolenic acid; Q, quartile.
J.-S. Zheng et al. / Clinical Nutrition xxx (2018) 1e7 5our present study makes a valuable contribution to the sparse
literature investigating the prospective association between blood
n-3 PUFA biomarkers and T2D in Asians. The reason for the in-
consistencies between the results from our cohort and Western
cohorts might be because levels of marine n-3 PUFA (median: DPA
1.54% and EPA 0.55%) in our cohort were lower than those found in
Western cohorts using measurement of erythrocyte or erythrocyte
phospholipid fatty acids (median: DPA >2.2%, EPA>0.75%) [8,10,12].
Though a potential threshold effect/non-linear association might
exist, we did not observe such association in our study. Another
possibility is the inﬂuence of covariate adjustment. The inverse
association between T2D and DPA/EPA was observed after adjust-
ment for circulating fasting glucose and n-6 PUFA. This suggests
that baseline glycemic traits and n-6 PUFA context may have
confounded the n-3 PUFA and T2D associations, which were rarely
considered or adjusted for in prior studies [7].
Although we observed an inverse association between T2D and
EPA/DPA, there was no association for DHA. In addition, the results
for EPAwere consistent with the ratio of EPA/AA. Indeed, compared
with DHA, EPA has a stronger anti-inﬂammatory effect [31],Please cite this article in press as: Zheng J-S, et al., Association of erythroc
Chinese population, Clinical Nutrition (2018), https://doi.org/10.1016/j.clnthrough which EPA might be linked with a lower risk of T2D [32].
EPA competes with AA for access to cyclooxygenase and produces
an alternative form of thromboxane (TXA3) and prostaglandins
(PGI3), leading to reduced production of TXA2 and PGI2, important
pro-inﬂammatory eicosanoids [31,33]. In contrast to DHA and EPA,
DPA is a less well-investigated marine n-3 PUFA. Available evidence
suggests that DPA could inhibit the production of inﬂammatory
eicosanoids by competing with AA for the cyclooxygenase [34].
Nevertheless, the detailed mechanism underlying the effect of DPA
and EPA on glucose metabolism and glycemic traits remains un-
clear and warrants further investigation.
We did not ﬁnd a signiﬁcant association between T2D
and erythrocyte ALA. This result conﬂicts with previous ﬁndings
from the EPIC-InterAct and its comparative meta-analysis that
circulating ALA was inversely associated with T2D [7]. The
reason for this inconsistency is unclear. Nevertheless, among
studies using erythrocyte or erythrocyte phospholipid fatty acids
as biomarkers [8,10,12], none has found a statistically signiﬁcant
association between ALA and T2D, which is consistent with our
results.yte n-3 polyunsaturated fatty acids with incident type 2 diabetes in a
u.2018.09.018
Table 3
Association of dietary ﬁsh and n-3 fatty acids with incident type 2 diabetesa.
Dietary intake Multivariable-adjusted hazard ratio (95% CI)b
Q1 Q2 Q3 Q4 p-trend
Fish Median, g/d 15.5 32.4 52.7 92.9
No. of cases/person-years of follow-up 59/3152 52/3196 49/3525 53/3577
Model 1 1 (ref) 0.90 (0.62, 1.31) 0.75 (0.51, 1.11) 0.84 (0.58, 1.22) 0.26
Model 2 1 (ref) 0.91 (0.62, 1.35) 0.76 (0.51, 1.14) 0.85 (0.55, 1.30) 0.33
Model 3 1 (ref) 0.85 (0.57, 1.28) 0.76 (0.51, 1.15) 0.94 (0.60, 1.45) 0.63
Marine n-3 PUFA Median, g/d 0.021 0.042 0.068 0.12
No. of cases/person-years of follow-up 57/3356 50/3229 56/3388 50/3477
Model 1 1 (ref) 0.87 (0.59, 1.29) 0.98 (0.68, 1.42) 0.83 (0.57, 1.21) 0.46
Model 2 1 (ref) 0.83 (0.56, 1.23) 0.97 (0.66, 1.42) 0.76 (0.51, 1.15) 0.32
Model 3 1 (ref) 0.75 (0.50, 1.14) 0.87 (0.59, 1.29) 0.78 (0.52, 1.19) 0.39
DHA Median, g/d 0.011 0.024 0.039 0.067
No. of cases/person-years of follow-up 58/3335 49/3265 58/3378 48/3472
Model 1 1 (ref) 0.86 (0.59, 1.27) 0.97 (0.67, 1.41) 0.80 (0.54, 1.18) 0.37
Model 2 1 (ref) 0.82 (0.56, 1.22) 0.95 (0.65, 1.39) 0.73 (0.48, 1.10) 0.22
Model 3 1 (ref) 0.77 (0.51, 1.17) 0.87 (0.59, 1.30) 0.74 (0.49, 1.13) 0.26
DPA Median, g/d <0.001 0.002 0.004 0.01
No. of cases/person-years of follow-up 51/3404 56/3402 39/3205 67/3440
Model 1 1 (ref) 1.14 (0.78, 1.66) 0.85 (0.56, 1.28) 1.36 (0.94, 1.95) 0.25
Model 2 1 (ref) 1.10 (0.75, 1.62) 0.83 (0.54, 1.26) 1.34 (0.92, 1.95) 0.29
Model 3 1 (ref) 1.01 (0.67, 1.50) 0.61 (0.39, 0.95) 1.08 (0.74, 1.57) 0.84
EPA Median, g/d 0.008 0.016 0.025 0.042
No. of cases/person-years of follow-up 56/3354 50/3235 57/3388 50/3473
Model 1 1 (ref) 0.86 (0.58, 1.26) 0.97 (0.67, 1.41) 0.85 (0.58, 1.25) 0.57
Model 2 1 (ref) 0.81 (0.55, 1.20) 0.93 (0.63, 1.37) 0.78 (0.52, 1.18) 0.36
Model 3 1 (ref) 0.77 (0.51, 1.15) 0.85 (0.57, 1.27) 0.76 (0.50, 1.16) 0.30
ALA Median, g/d 0.49 0.66 0.84 1.19
No. of cases/person-years of follow-up 40/3366 57/3333 50/3420 66/3330
Model 1 1 (ref) 1.38 (0.92, 2.07) 1.23 (0.80, 1.87) 1.62 (1.08, 2.41) 0.04
Model 2 1 (ref) 1.40 (0.92, 2.12) 1.23 (0.80, 1.90) 1.67 (1.11, 2.52) 0.033
Model 3 1 (ref) 1.37 (0.90, 2.09) 1.11 (0.72, 1.71) 1.53 (1.01, 2.33) 0.12
a Abbreviations: EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid; ALA, alpha-linolenic acid; PUFA, polyunsaturated fatty acids; Q,
quartile.
b Multivariable-adjusted hazard ratios (95% CI) were calculated for quintiles 2 to 4 of the dietary ﬁsh or n-3 fatty acid intake, compared with quintile 1. Model 1
was adjusted for age, sex, BMI, and ratio of waist to hip circumference; model 2 included covariates in model 1 þ physical activity, education, alcohol drinking,
smoking, household income, family history of diabetes, total energy intake, and intake of dairy products, red and processed meat, fruits and vegetables; model 3
included covariates in model 2 þ fasting blood glucose and erythrocyte total n-6 PUFA. P-trend was estimated based on per quartile increase in the corresponding
fatty acid.
J.-S. Zheng et al. / Clinical Nutrition xxx (2018) 1e76There are several limitations in the present study. First, we
measured erythrocyte fatty acids only in baseline samples and did
not account for potential changes in n-3 PUFA composition over
time. Second, given the nature of an observational study, we could
not avoid the inﬂuence of residual confounders. Third, although
this is the largest study among Chinese populations with fatty acid
biomarkers and sufﬁcient incident T2D cases, we included only 213
incident T2D cases over a relatively moderate follow-up time.
Fourth, we measured erythrocyte fatty acids in a Chinese popula-
tion, and the generalizability of our results to other lipid fractions or
populations is limited. The strengths of the present study include
the use of objective biomarkers for the measurement of n-3 PUFA,
and adjustment for a variety of risk factors and several sensitivity
analyses, which support the robustness of our ﬁndings.
5. Conclusions
We offer evidence that erythrocyte EPA and DPA, as bio-
markers of dietary marine n-3 PUFA intake, are associated with
lower incidence of T2D. The current results regarding erythro-
cyte biomarkers add to the evidence that dietary intake of
marine n-3 PUFA is associated with lower risk of T2D in Asian
populations. Detailed investigation of the potential causality of
total and individual marine n-3 PUFA in T2D etiology is war-
ranted, using a Mendelian randomization approach in observa-
tional studies or randomized controlled trials, especially among
Asian participants.Please cite this article in press as: Zheng J-S, et al., Association of erythroc
Chinese population, Clinical Nutrition (2018), https://doi.org/10.1016/j.clnFunding
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